CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 56 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2022. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14 | -30.0% | 16,500 | -5.7% | 0.00% | – |
| Q2 2023 | $20 | +11.1% | 17,500 | 0.0% | 0.00% | – |
| Q1 2023 | $18 | -10.0% | 17,500 | 0.0% | 0.00% | – |
| Q4 2022 | $20 | -99.9% | 17,500 | -32.7% | 0.00% | – |
| Q3 2022 | $29,000 | -23.7% | 26,000 | 0.0% | 0.00% | – |
| Q2 2022 | $38,000 | -36.7% | 26,000 | 0.0% | 0.00% | – |
| Q1 2022 | $60,000 | -31.8% | 26,000 | -18.5% | 0.00% | – |
| Q4 2021 | $88,000 | -65.8% | 31,900 | -25.6% | 0.00% | -100.0% |
| Q3 2021 | $257,000 | +74.8% | 42,850 | +41.9% | 0.00% | 0.0% |
| Q2 2021 | $147,000 | +88.5% | 30,200 | -3.8% | 0.00% | – |
| Q1 2021 | $78,000 | +188.9% | 31,400 | +214.0% | 0.00% | – |
| Q4 2020 | $27,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |